Skip to content

Clinical trials

Temporomandibular Joint Disorders trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Temporomandibular Joint Disorders Phase: Not applicable Clear all

347 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20073
20081
20093
20105
20115
20125
20135
20149
201510
201617
201710
201813
201921
202014
202124
202227
202345
202445
202543
202634

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed190
Unknown status57
Recruiting42
Not yet recruiting36
Active, not recruiting6
Enrolling by invitation6
Terminated5
Withdrawn5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cairo University20
University of Nove de Julho11
Istanbul University5
Riphah International University5
Tokat Gaziosmanpasa University5
Hacettepe University4
Istanbul Medipol University Hospital4
Karolinska Institutet4
Marmara University4
Pomeranian Medical University Szczecin4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Temporomandibular Joint Disorders347
Facial Pain37
Pain34
Temporomandibular Joint Dysfunction Syndrome17
Chronic Pain15
Bruxism13
Myalgia11
Myofascial Pain Syndromes11
Agnosia9
Neck Pain9

Trials

Showing 51 to 75 of 347. Each trial links to its page on Pharma Observatory.

247 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.